{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:17:14Z","timestamp":1792264634155,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-026-14275-x","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:26:13Z","timestamp":1774517173000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cross-national disparities in end-of-life outcomes and care strategies for Parkinson\u2019s disease: a systematic review and meta-analysis of China and the United States"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"11","key":"14275_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"GBD 2016 Parkinson\u2019s Disease Collaborators","year":"2018","unstructured":"GBD 2016 Parkinson\u2019s Disease Collaborators. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"issue":"s1","key":"14275_CR2","first-page":"S3","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The Emerging Evidence of the Parkinson Pandemic. J Park Dis. 2018;8(s1):S3\u20138.","journal-title":"J Park Dis"},{"key":"14275_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-019-0162-z","volume":"8","author":"G Li","year":"2019","unstructured":"Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, et al. Parkinson\u2019s disease in China: a forty-year growing track of bedside work. Transl Neurodegener. 2019;8:22.","journal-title":"Transl Neurodegener"},{"key":"14275_CR4","first-page":"101078","volume":"46","author":"T Xu","year":"2024","unstructured":"Xu T, Dong W, Liu J, Yin P, Wang Z, Zhang L, et al. Disease burden of Parkinson\u2019s disease in China and its provinces from 1990 to 2021: findings from the global burden of disease study 2021. Lancet Reg Health West Pac. 2024;46:101078.","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"14275_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12913-023-09203-2","volume":"23","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhang R, Lou Y, Li W, Yang H. Facilitators and barriers to the delivery of palliative care to patients with Parkinson\u2019s disease: a qualitative study of the perceptions and experiences of stakeholders using the socio-ecological model. BMC Health Serv Res. 2023;23(1):215.","journal-title":"BMC Health Serv Res"},{"key":"14275_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, et al. Prevalence of Parkinson\u2019s disease across North America. NPJ Park Dis. 2018;4:21.","journal-title":"NPJ Park Dis"},{"key":"14275_CR7","doi-asserted-by":"crossref","unstructured":"Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity. Am J Epidemiol. 2003 June 1;157(11):1015\u201322.","DOI":"10.1093\/aje\/kwg068"},{"key":"14275_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2020.02.018","volume":"71","author":"O Okunoye","year":"2020","unstructured":"Okunoye O, Kojima G, Marston L, Walters K, Schrag A. Factors associated with hospitalisation among people with Parkinson\u2019s disease - A systematic review and meta-analysis. Parkinsonism Relat Disord. 2020;71:66\u201372.","journal-title":"Parkinsonism Relat Disord"},{"key":"14275_CR9","doi-asserted-by":"crossref","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet Lond Engl. 2021 June 12;397(10291):2284\u2013303.","DOI":"10.1016\/S0140-6736(21)00218-X"},{"issue":"5","key":"14275_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/jamaneurol.2019.4992","volume":"77","author":"BM Kluger","year":"2020","unstructured":"Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, et al. Comparison of integrated outpatient palliative care with standard care in patients with parkinson disease and related disorders: a randomized clinical trial. JAMA Neurol. 2020;77(5):551\u201360.","journal-title":"JAMA Neurol"},{"issue":"5","key":"14275_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1212\/WNL.0000000000001715","volume":"85","author":"D Safarpour","year":"2015","unstructured":"Safarpour D, Thibault DP, DeSanto CL, Boyd CM, Dorsey ER, Racette BA, et al. Nursing home and end-of-life care in Parkinson disease. Neurology. 2015;85(5):413\u20139.","journal-title":"Neurology"},{"issue":"3","key":"14275_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.5582\/bst.2024.01180","volume":"18","author":"H Wang","year":"2024","unstructured":"Wang H, Qin D, Fang L, Liu H, Song P. Addressing healthy aging in China: Practices and prospects. Biosci Trends. 2024;18(3):212\u20138.","journal-title":"Biosci Trends"},{"issue":"2","key":"14275_CR13","doi-asserted-by":"publisher","first-page":"e200138","DOI":"10.1212\/CPJ.0000000000200138","volume":"13","author":"WW Aamodt","year":"2023","unstructured":"Aamodt WW, Willis AW, Dahodwala N. Racial and Ethnic Disparities in Parkinson Disease: A Call to Action. Neurol Clin Pract. 2023;13(2):e200138.","journal-title":"Neurol Clin Pract"},{"key":"14275_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"14275_CR15","doi-asserted-by":"crossref","unstructured":"Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010 Sept;25(9):603\u20135.","DOI":"10.1007\/s10654-010-9491-z"},{"key":"14275_CR16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"issue":"4","key":"14275_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"14275_CR18","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003 Sept 6;327(7414):557\u201360.","DOI":"10.1136\/bmj.327.7414.557"},{"issue":"3","key":"14275_CR19","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s00415-021-10784-3","volume":"269","author":"Y Xu","year":"2022","unstructured":"Xu Y, Surface M, Chan AK, Halpern J, Vanegas-Arroyave N, Ford B, et al. COVID-19 manifestations in people with Parkinson\u2019s disease: a USA cohort. J Neurol. 2022;269(3):1107\u201313.","journal-title":"J Neurol"},{"key":"14275_CR20","doi-asserted-by":"crossref","unstructured":"Fasano A, Cereda E, Barichella M, Cassani E, Ferri V, Zecchinelli AL, et al. COVID-19 in Parkinson\u2019s Disease Patients Living in Lombardy, Italy. Mov Disord Off J Mov Disord Soc. 2020 July;35(7):1089\u201393.","DOI":"10.1002\/mds.28176"},{"key":"14275_CR21","doi-asserted-by":"crossref","unstructured":"Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson\u2019s disease. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 1995 June;4(3):241\u20138.","DOI":"10.1007\/BF02260863"},{"key":"14275_CR22","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.parkreldis.2019.06.018","volume":"65","author":"SK Holden","year":"2019","unstructured":"Holden SK, Koljack CE, Prizer LP, Sillau SH, Miyasaki JM, Kluger BM. Measuring quality of life in palliative care for Parkinson\u2019s disease: A clinimetric comparison. Parkinsonism Relat Disord. 2019;65:172\u20137.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"14275_CR23","doi-asserted-by":"publisher","first-page":"e250014","DOI":"10.1001\/jamanetworkopen.2025.0014","volume":"8","author":"M Bock","year":"2025","unstructured":"Bock M, Gan S, Aldridge M, Harrison KL, Yaffe K, Smith AK, et al. Hospice Use Among Medicare Beneficiaries With Parkinson Disease and Dementia With Lewy Bodies. JAMA Netw Open. 2025;8(3):e250014.","journal-title":"JAMA Netw Open"},{"key":"14275_CR24","doi-asserted-by":"crossref","unstructured":"Zhong X, Song PP, Wang Z, Chen H. Resilience building among Chinese family caregivers of older people with Parkinson\u2019s disease in Shanghai. Health Soc Care Community. 2022 Sept;30(5):e2395\u2013405.","DOI":"10.1111\/hsc.13679"},{"issue":"1","key":"14275_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12877-019-1403-9","volume":"20","author":"Y Zhong","year":"2020","unstructured":"Zhong Y, Wang J, Nicholas S. Social support and depressive symptoms among family caregivers of older people with disabilities in four provinces of urban China: the mediating role of caregiver burden. BMC Geriatr. 2020;20(1):3.","journal-title":"BMC Geriatr"},{"key":"14275_CR26","doi-asserted-by":"crossref","unstructured":"Kluger BM, Hudson P, Hanson LC, Bu\u017egov\u00e0 R, Creutzfeldt CJ, Gursahani R, et al. Palliative care to support the needs of adults with neurological disease. Lancet Neurol. 2023 July;22(7):619\u201331.","DOI":"10.1016\/S1474-4422(23)00129-1"},{"key":"14275_CR27","doi-asserted-by":"crossref","unstructured":"Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, et al. Physiotherapy versus placebo or no intervention in Parkinson\u2019s disease. Cochrane Database Syst Rev. 2013 Sept 10;2013(9):CD002817.","DOI":"10.1002\/14651858.CD002817.pub4"},{"issue":"5","key":"14275_CR28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jama.2012.207624","volume":"309","author":"JM Teno","year":"2013","unstructured":"Teno JM, Gozalo PL, Bynum JPW, Leland NE, Miller SC, Morden NE, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009. JAMA. 2013;309(5):470\u20137.","journal-title":"JAMA"},{"issue":"8","key":"14275_CR29","doi-asserted-by":"publisher","first-page":"e1004670","DOI":"10.1371\/journal.pmed.1004670","volume":"22","author":"S Wang","year":"2025","unstructured":"Wang S, Hu W, Gao Y, Wang A, Chen L, Liang Z, et al. Deep brain stimulation surgical timing, outcomes, and prognostic factors in patients with Parkinson\u2019s disease: A Chinese retrospective multicenter cohort study. PLoS Med. 2025;22(8):e1004670.","journal-title":"PLoS Med"},{"issue":"9","key":"14275_CR30","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa060281","volume":"355","author":"G Deuschl","year":"2006","unstructured":"Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Sch\u00e4fer H, B\u00f6tzel K, et al. A randomized trial of deep-brain stimulation for Parkinson\u2019s disease. N Engl J Med. 2006;355(9):896\u2013908.","journal-title":"N Engl J Med"},{"issue":"2","key":"14275_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1212\/WNL.0000000000000017","volume":"82","author":"AW Willis","year":"2014","unstructured":"Willis AW, Schootman M, Kung N, Wang XY, Perlmutter JS, Racette BA. Disparities in deep brain stimulation surgery among insured elders with Parkinson disease. Neurology. 2014;82(2):163\u201371.","journal-title":"Neurology"},{"issue":"4","key":"14275_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3233\/NRE-192894","volume":"45","author":"PB Perrin","year":"2019","unstructured":"Perrin PB, Henry RS, Donovan EK, Cariello AN, Lageman SK, Villase\u00f1or T, et al. Parkinson\u2019s family needs and caregiver mental health: A cross-cultural comparison between Mexico and the United States. NeuroRehabilitation. 2019;45(4):433\u201342.","journal-title":"NeuroRehabilitation"},{"key":"14275_CR33","first-page":"100599","volume":"26","author":"C Sarica","year":"2023","unstructured":"Sarica C, Conner CR, Yamamoto K, Yang A, Germann J, Lannon MM, et al. Trends and disparities in deep brain stimulation utilization in the United States: a Nationwide Inpatient Sample analysis from 1993 to 2017. Lancet Reg Health Am. 2023;26:100599.","journal-title":"Lancet Reg Health Am"},{"key":"14275_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-020-0117-1","volume":"6","author":"W Yang","year":"2020","unstructured":"Yang W, Hamilton JL, Kopil C, Beck JC, Tanner CM, Albin RL, et al. Current and projected future economic burden of Parkinson\u2019s disease in the U.S. NPJ Park Dis. 2020;6:15.","journal-title":"NPJ Park Dis"},{"issue":"2","key":"14275_CR35","first-page":"565","volume":"14","author":"HI Ma","year":"2005","unstructured":"Ma HI, Hwang WJ, Chen-Sea MJ. Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson\u2019s Disease Questionnaire (PDQ-39). Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2005;14(2):565\u20139.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"1","key":"14275_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/mdc3.12349","volume":"4","author":"RL Yu","year":"2017","unstructured":"Yu RL, Wu RM, Chan AYY, Mok V, Wu YR, Tilley BC, et al. Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson\u2019s Disease Rating Scale. Mov Disord Clin Pract. 2017;4(1):68\u201377.","journal-title":"Mov Disord Clin Pract"},{"issue":"Suppl 1","key":"14275_CR37","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.21037\/apm.2019.11.12","volume":"9","author":"M Katz","year":"2020","unstructured":"Katz M. Telehealth increases access to palliative care for people with Parkinson\u2019s disease and related disorders. Ann Palliat Med. 2020;9(Suppl 1):S75\u20139.","journal-title":"Ann Palliat Med"},{"issue":"3","key":"14275_CR38","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cns.13549","volume":"27","author":"N Zhao","year":"2021","unstructured":"Zhao N, Yang Y, Zhang L, Zhang Q, Balbuena L, Ungvari GS, et al. Quality of life in Parkinson\u2019s disease: A systematic review and meta-analysis of comparative studies. CNS Neurosci Ther. 2021;27(3):270\u20139.","journal-title":"CNS Neurosci Ther"},{"issue":"2","key":"14275_CR39","doi-asserted-by":"publisher","first-page":"e200273","DOI":"10.1212\/CPJ.0000000000200273","volume":"14","author":"ME Goetz","year":"2024","unstructured":"Goetz ME, Ford CB, Greiner MA, Clark A, Johnson KG, Kaufman BG, et al. Racial Disparities in Low-Value Care in the Last Year of Life for Medicare Beneficiaries With Neurodegenerative Disease. Neurol Clin Pract. 2024;14(2):e200273.","journal-title":"Neurol Clin Pract"},{"key":"14275_CR40","doi-asserted-by":"crossref","unstructured":"Etkind SN, Bone AE, Lovell N, Cripps RL, Harding R, Higginson IJ, et al. The role and response of palliative care and hospice services in epidemics and pandemics: a rapid review to inform practice during the covid-19 pandemic. J Pain Symptom Manage. 2020 July;60(1):e31\u201340.","DOI":"10.1016\/j.jpainsymman.2020.03.029"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-14275-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-14275-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:10:27Z","timestamp":1777947027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-026-14275-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["14275"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-14275-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8124753\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"16 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This systematic review and meta-analysis was conducted in accordance with the Declaration of Helsinki and following PRISMA 2020 guidelines. As this study constitutes secondary analysis of previously published literature, formal ethics approval from an Institutional Review Board was not required. The study protocol was reviewed and approved by the Research Ethics Committee of the 904th Hospital of the Joint Logistics Support Force of PLA (approval number: 2024010), confirming that the systematic review methodology complies with ethical standards for secondary data analysis research. Individual patient consent was not applicable as no original human participant data were collected; all included studies were required to have obtained appropriate informed consent from participants as per their respective institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain any individual person\u2019s data in any form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"635"}}